FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

17569911000001109: Maxalt 5mg tablets (Sigma Pharmaceuticals Plc) 6 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 25-Aug 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
60733001000001116 Maxalt 5mg tablets (Sigma Pharmaceuticals Plc) 6 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
60733101000001115 Maxalt 5mg tablets (Sigma Pharmaceuticals Plc) 6 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Maxalt 5mg tablets (Sigma Pharmaceuticals Plc) 6 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Maxalt 5mg tablets (Sigma Pharmaceuticals Plc) 6 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Maxalt 5mg tablets (Sigma Pharmaceuticals Plc) 6 tablet Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Maxalt 5mg tablets (Sigma Pharmaceuticals Plc) 6 tablet Is a Rizatriptan 5mg tablets 6 tablet true Inferred relationship Existential restriction modifier
Maxalt 5mg tablets (Sigma Pharmaceuticals Plc) 6 tablet Has AMP Maxalt 5mg tablets (Sigma Pharmaceuticals Plc) true Inferred relationship Existential restriction modifier
Maxalt 5mg tablets (Sigma Pharmaceuticals Plc) 6 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Maxalt 5mg tablets (Sigma Pharmaceuticals Plc) 6 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Maxalt 5mg tablets (Sigma Pharmaceuticals Plc) 6 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Maxalt 5mg tablets (Sigma Pharmaceuticals Plc) 6 tablet Has specific active ingredient Rizatriptan benzoate true Inferred relationship Existential restriction modifier
Maxalt 5mg tablets (Sigma Pharmaceuticals Plc) 6 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Maxalt 5mg tablets (Sigma Pharmaceuticals Plc) 6 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Rizatriptan true Inferred relationship Existential restriction modifier
Maxalt 5mg tablets (Sigma Pharmaceuticals Plc) 6 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Maxalt 5mg tablets (Sigma Pharmaceuticals Plc) 6 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Maxalt 5mg tablets (Sigma Pharmaceuticals Plc) 6 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Maxalt 5mg tablets (Sigma Pharmaceuticals Plc) 6 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Maxalt 5mg tablets (Sigma Pharmaceuticals Plc) 6 tablet Has basis of strength substance Rizatriptan true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start